| PERIOD ENDING | 31-Oct-09 | 1-Aug-09 | 2-May-09 | 31-Jan-09 | | Total Revenue | 989,816 | 1,126,767 | 959,662 | 1,207,532 | | Cost of Revenue | 722,986 | 816,866 | 709,239 | 855,348 | | | Gross Profit | 266,830 | 309,901 | 250,423 | 352,184 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 230,430 | 238,745 | 226,123 | 241,675 | | Non Recurring | 4,645 | 7,328 | 7,383 | 203,378 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 31,755 | 63,828 | 16,917 | (92,869) | | | Income from Continuing Operations | | Total Other Income/Expenses Net | (1,218) | 962 | 256 | (37) | | Earnings Before Interest And Taxes | 28,683 | 64,790 | 17,173 | (92,906) | | Interest Expense | (2,899) | 1,052 | 1,847 | 3,937 | | Income Before Tax | 31,582 | 63,738 | 15,326 | (96,843) | | Income Tax Expense | 12,728 | 24,813 | 5,105 | 7,533 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 18,854 | 38,925 | 10,221 | (104,376) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 18,854 | 38,925 | 10,221 | (104,376) | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $18,854 | $38,925 | $10,221 | ($104,376) |
|
0.26% Nasdaq 
Income Statement
